Clinical Trial Update: Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hydroxychloroquine for nonalcoholic steatohepatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Steatohepatitis, Nonalcoholic | Phase 3 | Status: RECRUITING